TLX - Telix Pharmaceuticals Limited News

Profound Medical Signs Agreement With Telix Pharmaceuticals To Educate Urologists, Radiologists, Nuc

Profound Medical Corp. (NASDAQ:PROF, TSX:PRN) ("Profound" or the "Company"), a comme

Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Pro

Collaboration will educate physicians and prostate cancer centers on the complementary roles of Teli

Telix Pharmaceuticals Says First Patients In US Dosed With Pixclara, FDA-Approved, Amino Acid Positr

First doses of Pixclara administered in Cleveland (OH) and Indianapolis (IN) marking the start of U.

First Patients Dosed with Telix's FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F

MELBOURNE, Australia and INDIANAPOLIS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limit

IBA and Telix strengthen ties through agreement to distribute ARTMS's QIS®

IBA to offer QUANTM® Irradiation System solid-target technology to cyclotron users worldwide, scalin

zacks.com

Wall Street Analysts Believe Telix Pharmaceuticals Limited (TLX) Could Rally 83.42%: Here's is How t

The average of price targets set by Wall Street analysts indicates a potential upside of 83.4% in Te

defenseworld.net

Telix Pharmaceuticals (NASDAQ:TLX) Sees Unusually-High Trading Volume – What’s Next?

Telix Pharmaceuticals Limited (NASDAQ: TLX - Get Free Report) saw unusually-strong trading volume on

HC Wainwright & Co. Reiterates Buy on Telix Pharmaceuticals, Maintains $20 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates Telix Pharmaceuticals (NASDAQ:TLX) with a

Wedbush Reiterates Outperform on Telix Pharmaceuticals, Maintains $22 Price Target

Wedbush analyst David Nierengarten reiterates Telix Pharmaceuticals (NASDAQ:TLX) with a Outperfor

Telix Pharmaceuticals Limited (TLX) Discusses Strategic Overview and Oncology Pipeline at Research a

Telix Pharmaceuticals Limited (TLX) M&A Call Transcript

Crude Oil Down 4%; Intel Shares Move Higher

U.S. stocks climbed Monday, led by Nasdaq (+1.77%) and Intel (+10%); communication shares rallied, w

Telix Makes $1.65 Billion Bet on ITM to Build a Radiopharma Powerhouse

Telix Pharmaceuticals acquires ITM Isotope for $1.65B to create a radiopharmaceutical leader. Here i

Reported September 20, 2026: 'Australia's Telix Pharma Agrees To Buy Germany's ITM Isotope For About

https://www.reuters.com/legal/transactional/australias-telix-pharma-agrees-buy-germanys-itm-isotope-

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Greenland Mines (NASDAQ:GRML) stock rose 108.1% to $5.93 during Monday's pre-market ses

Novo Nordisk, Telix Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

U.S. futures rose, but Novo Nordisk fell 4.8% after Cagrisema trial results; Aligos, Telix and other

Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket

Lobo Technologies shares surged 32% premarket after a narrower H1 loss and higher sales; several sma

Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse

MELBOURNE, Australia and INDIANAPOLIS and MUNICH, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceu

reuters.com

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

Australia's Telix Pharmaceuticals said on ‌Monday it has agreed to acquire Germany-based ITM ⁠Iso

Telix Pharmaceuticals: 'Buy' On Pixclara FDA Approval And TLX591-Tx Part 2 Advancement

Telix Pharmaceuticals is maintained at a “Buy” rating, supported by FDA approval of PIXCLARA and rob

HC Wainwright & Co. Reiterates Buy on Telix Pharmaceuticals, Maintains $20 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates Telix Pharmaceuticals (NASDAQ:TLX) with a

Radiant Logistics, Waystar, Forgent Power Solutions And Other Big Stocks Moving Higher On Tuesday

U.S. stocks fell, but Radiant Logistics surged 17.8% after beating Q4 estimates. Waystar, Telix and

fool.com

Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

Novo Nordisk is bigger and more profitable on paper, but pricing pressure, reduced Medicaid coverage

Telix Pharmaceuticals Limited (TLX) Presents at Morgan Stanley 24th Annual Global Healthcare Confere

FDA Approves Telix Pharmaceuticals Brain Cancer Imaging Drug

On Monday, the U.S. Food and Drug Administration (FDA) approved Pixclara (floretyrosine F18), an ami

FDA Approves Telix Pharmaceuticals Brain Cancer Imaging Drug

FDA approves Telix Pharmaceuticals' Pixclara, the first radiopharmaceutical brain cancer imaging

Wedbush Reiterates Outperform on Telix Pharmaceuticals, Maintains $22 Price Target

Wedbush analyst David Nierengarten reiterates Telix Pharmaceuticals (NASDAQ:TLX) with a Outperfor

FDA Approves Telix Pharma’s NDA For Pixclara, Amino Acid Positron Emission Tomography Drug For Imagi

Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer).Approval addresse

FDA Approves Telix's Brain Cancer Imaging Drug Pixclara

MELBOURNE, Australia and INDIANAPOLIS, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limi

Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Scholar Rock surged 11.9% after FDA approved ISEMBYLD for SMA; Scinai, Intercont and Rum led premark

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright

MELBOURNE, Australia and INDIANAPOLIS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limi

Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday

U.S. stocks rose; Sirius XM jumped 5.5% after Deutsche Bank’s upgrade, while GitLab, Dell and other

HC Wainwright & Co. Reiterates Buy on Telix Pharmaceuticals, Maintains $20 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates Telix Pharmaceuticals (NASDAQ:TLX) with a

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

MELBOURNE, Australia and INDIANAPOLIS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limi

Reported Earlier, Telix Names David Gill Board Chair As Mark Nelson Steps Down From Interim Role

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ:TLX, "Telix" or the "Company") today

Telix Appoints David Gill as Chair

MELBOURNE, Australia and INDIANAPOLIS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limi

Telix Pharmaceuticals: Execution Is The Name Of The Game Here

Telix Pharmaceuticals has rebounded strongly, reaching profitability and guiding FY2026 revenue to $

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares moved upwards by 74.6% to $0.75 during Friday&#3

Wedbush Reiterates Outperform on Telix Pharmaceuticals, Maintains $22 Price Target

Wedbush analyst David Nierengarten reiterates Telix Pharmaceuticals (NASDAQ:TLX) with a Outperfor

Reported Earlier, Telix Pharmaceuticals Guides FY 2026 Revenue Of $950M-$970M, Total Income Above $1

GuidanceFY 2026 revenue and other income are expected to be in excess of US$1 billion, with revenue

Telix Pharmaceuticals Limited (TLX) Q2 2026 Earnings Call Transcript

marketbeat.com

Telix Pharmaceuticals H1 Earnings Call Highlights

Telix Pharmaceuticals NASDAQ: TLX reported first-half 2026 revenue of $477 million, up 22% from the

Telix Pharmaceuticals Announces Publication Of Results From The ProstACT SELECT Study In Cancers, A

Peer-reviewed publication of ProstACT SELECT1 results confirm the utility of 68Ga (gallium)-PSMA-PET

Telix Pharmaceuticals Announces That The First Patient Has Been Dosed With TLX250-Tx In The LUTEON S

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ:TLX, "Telix") today announced that the first

Citigroup Maintains Buy on Telix Pharmaceuticals, Lowers Price Target to $22

Citigroup analyst Laura Sutcliffe maintains Telix Pharmaceuticals (NASDAQ:TLX) with a Buy and low

HC Wainwright & Co. Reiterates Buy on Telix Pharmaceuticals, Maintains $20 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates Telix Pharmaceuticals (NASDAQ:TLX) with a

Wedbush Reiterates Outperform on Telix Pharmaceuticals, Maintains $22 Price Target

Wedbush analyst David Nierengarten reiterates Telix Pharmaceuticals (NASDAQ:TLX) with a Outperfor

Telix Pharmaceuticals Signs MoU With United Imaging Healthcare North America To Evaluate A U.S. Rese

Partnership to evaluate Telix's innovative precision medicine products and candidates in combina

Telix Pharmaceuticals' IPAX-2 Study Of TLX101-Tx Completes Patient Enrolment; Maximum Dose Reached

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ:TLX, "Telix") today announces that the IPAX-